Company news
Dimerix Limited news in 2017
Dimerix Limited's news releases, calls and decks from 2017, newest first.
Proteomics partnership to improve treatment of CKD
December 13, 2017
Entitlement Offer Booklet
December 5, 2017
Entitlement Offer to raise $5.5 million
December 5, 2017
Suspension from Official Quotation
December 4, 2017
Dimerix Phase 2a Subgroup Analysis Results
November 1, 2017
Ethics Committee Approval for Pharmacokinetic Trial
October 23, 2017
Dimerix Receives $545k R&D Tax Refund
October 17, 2017
Notice of Annual General Meeting/Proxy Form
September 12, 2017
DMX-200 tablet manufacture and human study timeline
September 4, 2017
Positive Results from Phase 2a Trial of DMX-200
July 12, 2017
Research Validates Relevance of DMX Receptor-HIT Technology
June 12, 2017
Investor Update
April 10, 2017
Receipt of $420k Research & Development Tax Refund
March 21, 2017
Corporate Presentation
February 13, 2017
Key Patent Allowed in Japan
January 30, 2017
Dimerix Raises $2 million to Advance Clinical Program
January 24, 2017
Decks in 2017
- Investor Presentation (November 2017)
Investor deck · 24 slides · Nov 22, 2017
- BioEurope 2017
Conference · 16 slides · Nov 8, 2017
- Corporate Update (November 2017)
Corporate update · 31 slides · Nov 2, 2017
- Shareholder Meeting (October 2017)
Shareholder meeting · 15 slides · Oct 19, 2017
- Broker Meets Biotech (September 2017)
Conference · 13 slides · Sep 13, 2017
- Investor Presentation (July 2017)
Investor deck · 18 slides · Jul 12, 2017
- Gold Coast Investment Showcase (June 2017)
Conference · 15 slides · Jun 22, 2017
- Investor Presentation (February 2017)
Investor deck · 19 slides · Feb 14, 2017
- Investor Presentation (January 2017)
Investor deck · 12 slides · Jan 25, 2017